Objective: To improve the management of obese adults (18-75 y) in primary care. Design: Cohort study. Settings: UK primary care. Subjects: Obese patients (body mass index Z30 kg/m 2 ) or BMIZ28 kg/m 2 with obesity-related comorbidities in 80 general practices. Intervention: The model consists of four phases: (1) audit and project development, (2) practice training and support, (3) nurse-led patient intervention, and (4) evaluation. The intervention programme used evidence-based pathways, which included strategies to empower clinicians and patients. Weight Management Advisers who are specialist obesity dietitians facilitated programme implementation. Main outcome measures: Proportion of practices trained and recruiting patients, and weight change at 12 months. Results: By March 2004, 58 of the 62 (93.5%) intervention practices had been trained, 47 (75.8%) practices were active in implementing the model and 1549 patients had been recruited. At 12 months, 33% of patients achieved a clinically meaningful weight loss of 5% or more. A total of 49% of patients were classed as 'completers' in that they attended the requisite number of appointments in 3, 6 and 12 months. 'Completers' achieved more successful weight loss with 40% achieving a weight loss of 5% or more at 12 months.
Introduction
In line with the world-wide epidemic of obesity, the prevalence of obesity in England has trebled over the past 20 y from 6 to 21% of the population in men and 8 to 23.5% in women (Bajekal et al, 2001) . The rising prevalence of obesity is a major public health concern with implications at an individual level of obesity-related disease and impaired quality of life, and a burden on healthcare resources at the population level (Lean et al, 1999; Must et al, 1999) . Two-thirds of the UK population are visiting their general practitioner (GP) at least annually, so primary care is an important setting to tackle the obesity epidemic (Bourn, 2001) . Primary care remains the public's preferred source of food and health information (Hiddink et al, 1997) and there is evidence that patients' attitudes towards practice-based lifestyle interventions are positive (Wallace & Haines, 1984; Wallace et al, 1987; Richmond et al, 1996) . Furthermore, patients who are advised to lose weight by a doctor are significantly more likely to attempt to do so than those not advised (Levy & Williamson, 1998; Galuska et al, 1999) .
GPs and primary care nurses (PCNs) believe weight management is part of their role, but perceive their effectiveness as poor (Campbell et al, 2000; Counterweight Project Team, 2004a) . Foster et al (2003) found that the treatment of obesity was rated as significantly less effective than therapies for nine out 10 chronic diseases. Evidence also suggests that patients have a poor acceptance of such interventions and that they rate physicians' traditional approach to weight management as unhelpful (Murphee, 1994; Evans, 1999; Wadden et al, 2000; Bramlage et al, 2004) . The approaches most likely to support patients in achieving lifestyle change such as long-term follow-up, self-monitoring and social support are the least likely to be considered important, or practised in primary care (Campbell et al, 2000; Wadden et al, 2000; Bramlage et al, 2004) .
Furthermore, health professionals including primary care clinicians often hold negative attitudes towards overweight or obese patients and this may impede practitioner and patient interaction (Cade & O'Connell, 1991; Hoppe & Ogden, 1997; Foster et al, 2003) . Primary care clinicians perceived ineffectiveness in helping patients lose weight and patients' failed weight loss attempts may result in perceived helplessness for clinician and patient.
Despite consistent evidence for important clinical benefits from moderate weight loss and weight maintenance in largescale clinical trials (Wing & Hill, 2001; Knowler et al, 2002; Tuomilehto et al, 2001) , few studies have been published on the effectiveness of weight management interventions in primary care. Studies have shown that the provision of training alone to GPs and PCNs on nutrition or weight management can improve knowledge and perceived confidence, but does not change clinician behaviour or improve patient outcomes (Cadman & Findlay, 1998; Moore et al, 2003a, b; Wollard et al, 2003) .
While few models of best practice have been identified (Bourn, 2001) , it is likely that a more comprehensive approach to empowering clinicians to change clinical practice is required. Multi-faceted interventions that target practice systems are more effective than single interventions (Grimshaw et al, 2001; Frijling et al, 2003; Margolis et al, 2004; Welschen et al, 2004) . Furthermore, the adoption of evidence-based approaches to weight management using an interactive model of communication is critical to empowering patients. Patient empowerment is defined as the process through which people gain greater control over decisions and actions affecting their health. Three important dimensions of patient empowerment have been identified including patient participation, patient control and patient education (Ouschan et al, 2000) .
The Counterweight Programme was established to improve the management of obesity in primary care through the implementation of a complex intervention incorporating changes to clinician behaviour and practice systems. The programme draws on theory and evidence relating to changing health professionals' behaviour and clinical care, as well as evidence-based interventions for obesity management centred on an interactive model of care. The purpose of this paper is to provide an overview of the Counterweight Programme, highlighting strategies used to empower clinicians and patients in weight management and the effectiveness of these approaches.
Methods
The Counterweight Programme is being conducted in seven regions of the UK: Aberdeen, Bath, Birmingham and Solihull, Glasgow, Hammersmith (London), Leeds and Luton. In all, 80 practices nationally were recruited with about 10 in each area, except Aberdeen where 20 practices were recruited (total n ¼ 80 nationally). Practices were chosen from those volunteering following letters of invitation. Practices varied in size, geographical location and deprivation category in order to be broadly representative. A total of 18 practices were randomised to act as controls to enable the Counterweight intervention to be assessed excluding confounding effects of other parallel local or national initiatives. Control practices were audited, but received no further intervention with the exception of the feedback of audit results. After 2 y, control and intervention practices were reaudited and the control practices offered training and intervention. The Counterweight Programme was approved by the West Midlands Multi-Centre Research Ethics Committee (MREC) and subsequently by Local Research Ethics Committees (LREC) in each region.
The Counterweight Programme consists of four phases: (1) audit and project development, (2) practice training and support, (3) nurse-led patient intervention, and (4) evaluation (Figure 1 ). The rationale and evidence base behind each phase of the programme is provided in detail elsewhere (Counterweight Project Team, 2004b) . At each phase of the programme, different strategies were used to empower both clinicians and patients to address weight management (Table 1) .
(1) Audit and project development: Local implementation of the programme was facilitated by a weight management adviser (WMA), a state registered dietitian with specialist experience in obesity management. At each centre, the programme was led by a secondary care clinician working in an obesity or diabetes centre. In most centres, a local steering group was established with representation from primary care, dietetics, health promotion and other relevant agencies. This was to allow collaboration with local stakeholders as part of a 'bottom-up approach' to encourage practice uptake of the programme (Table 1) .
The first phase of the Counterweight model conducted a baseline audit to determine current approaches to obesity management. Data were collected on weight screening rates, availability of clinical equipment and patient education materials as well as self-reported approaches to obesity management and perceived knowledge, attitudes, confidence and willingness to treat obese patients. These results are reported elsewhere (Reckless, 2003; Counterweight Project Team, 2004a ).
An important strategy to motivate practices to participate in the patient intervention programme was to obtain data on the health burden of obesity in each practice. In the first group of practices recruited, a detailed patient audit was conducted for 100 randomly selected obese patients (BMI Z30 kg/m 2 ). Computer-and paper-based medical records were retrospectively reviewed to examine patients' recorded weight history, weight management interventions, obesity related co-morbidities, drug prescribing, number of primary and secondary care appointments and hospital admissions over an 18-month retrospective period. In the second wave of practice recruitment, it was decided that a comparative audit in each practice of 50 obese (BMIZ30 kg/m 2 ) and 50 age-and sex-matched normal weight (BMI 18.5Ào25 kg/m 2 ) patients would provide more powerful data on the burden of obesity at the practice level. Results of this audit are published elsewhere (Laws & Reckless, 2003; Counterweight Project Team, 2004c .
(2) Practice-based training and support: The PCN was identified as the most suitable individual to deliver the weight management intervention. The main role of the GP
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Setting guidelines was to identify suitable patients for weight management intervention during routine clinical practice, refer on to the PCN and follow-up as required. This necessitated that the GPs agreed screening priorities within practices and were familiar with the pathway. It was envisaged that the GP intervention would be opportunistic and only 1-5 min duration to be feasible within a routine appointment. A 1 h workshop was conducted with GPs and centred on the use of the stages of change model (Prochaska et al, 1992) to identify patients suitable for the intervention. The workshop also aimed to increase GPs' confidence in raising weight as an issue and recognising the benefits of a 5-10% weight loss for the obese patient. PCN upskilling consisted of a 6-8 h training programme based around core competencies for evidence-based weight management intervention, the details of which are published elsewhere (Counterweight Project Team, 2004b) . Following the initial training, the WMA worked with the PCNs in clinical practice once or twice a month to cofacilitate clinics and patient groups until the desired level of competency had been reached. The involvement of an 'expert role model' or opinion leader has been shown to be a useful strategy in facilitating changes in clinical practice (Ogrinc et al, 2003 ; Table 1 ). After 6 months, practices generally required minimal support and WMA input after this time was mainly for the purpose of data collection and training new PCNs. The training programme for both GPs and PCNs centre on problem-based learning, using small interactive groups consistent with adult learning theory (Table 1) .
(3) Nurse-led patient intervention: The aim of the intervention programme was for patients to achieve a modest weight loss of Z5-10% of initial body weight, which is associated with clinical benefits (SIGN, 1996) . Clinicians were encouraged to implement a screening and treatment pathway, which was consistent with national and international evidence-based guidelines for obesity (SIGN, 1996; NIH, 1998; RCP, 2003) . The screening tool prioritised patients with a BMI Z30 or Z28 kg/m 2 with obesity-related comorbidities. All patients were offered a minimum of 3 months of lifestyle intervention as a first-line approach, provided in an individual or group format. PCNs were encouraged to see patients for six appointments (10-30 min each), over a 3-month period for individual intervention or for six group sessions lasting 1 h each. Follow-up appointments were recommended quarterly for all patients. Patients were defined as 'completers' if they attended four or more appointments in 3 months, five or more appointments in 6 months or six or more appointments in 12 months. This was considered the minimum number of appointments to have received the intervention. Details of the screening and treatment pathways and intervention types are published elsewhere (Counterweight Project Team, 2004b) . Participating practices agreed to restructure clinical work in order to deliver the model as part of routine clinical care. An important incentive for practice participation was achievement of government set national standards for coronary heart disease (CHD) and diabetes, whereby practices are required to have a structure in place for weight management (Department of Health, 2000 , 2001 . The WMA introduced reminder systems and prompts in practices, where possible, to encourage the clinicians to address weight management and to collect the required data. These prompts included a desktop flip chart for clinicians, recall letters for patients overdue for a review appointment and flags on the electronic medical notes. These empowerment strategies are consistent with economic, power and learning theories ( Table 1) .
The intervention programme was designed to empower the patient through increased patient participation, control and education (Table 1) . For example, the stages of change model require the clinician to seek the views of a patient on readiness to change. The use of a goal-setting approach involves the clinician negotiating appropriate lifestyle changes in a collaborative manner with the patient. This discourages the clinician from using more traditional prescription or persuasion models of communication. The programme also aimed to increase patients' sense of control through the use of self-monitoring techniques such as a food diary and the setting of realistic weight loss goals. Patient assessment and interaction were encouraged to ensure that patient education was tailored to the needs of the patient to avoid 'diet sheet approach' approach to weight management.
(4) Evaluation: A minimum patient data set was devised and included baseline weight, waist circumference, blood pressure, fasting lipids, glucose and HbA1c (diabetes only). These measures were repeated quarterly for 2 y with the exception of fasting bloods, which was repeated at 12 months for all patients and more frequently if clinically indicated. The WMA provided feedback to each practice on aggregated patient outcomes and results of other participating practices regionally and nationally. This was often carried out as part of a practice meeting with the aim of prompting discussions on strategies to improve patient outcomes at the practice level.
Results
Definitive results will not be available until study completion in 2005. As of March 2004, 58 of the 62 (93.5%) intervention practices had been trained and 47 (75.8%) practices were continuing to recruit actively patients into the programme. Four (6.5%) practices withdrew prior to training, and 11 (17.7%) practices have stopped recruiting patients. A total of 1549 patients had been recruited. At baseline, 74% had at least one obesity-related comorbidity, with 14% of patients having diabetes, 32% with hypertension, 13% having dyslipidaemia and 8% with CHD or angina. At the point of entry into the programme, the mean BMI was 36.9 kg/m 2 (s.d. 6) with 26% having a BMI greater than 40 kg/m 2 (classified as severely obese). The mean age at entry of 49 y (s.d. 13.5).
In accordance with the treatment pathway, 91% of patients received at least one of the core lifestyle interventions, and few patients received second-line interventions at baseline (Figure 2) . Over the 12-month intervention period, a proportion of patients progressed onto second-line interventions, with 22% of patients reaching 12 months receiving pharmacotherapy. Only a very small number of patients were referred outside of the practice for weight management intervention and no patients were referred to secondary care/specialist obesity centre (Figure 3) .
Indicative results are available for weight change at 3, 6 and 12 months for all patients and for completers ( Table 2) . A total of 49% of patients were classed as completers in that they attended the required level of appointments in 3, 6 and 12 months to receive the Counterweight intervention. Onethird of all patients who attended and followed up achieved clinically beneficial weight loss of 5% or more at 12 months. Furthermore, 40% of completers, those who completed the required number of appointments achieved loss of 5% or more at 12 months. Analysis on an intention-to-treat basis (ie including all those who did not complete the programme or attend for follow-up), one in six (16.2%) of all patients entering the programme achieved a clinically meaningful weight loss of 5% or more at 12 months.
Discussion
This is the first known study of its kind to use an evidencebased approach to up-skill clinicians to implement a new weight management approach, which aims to empower patients. Preliminary results indicate that the use of this Completers defined as patients attending a minimum of four appointments in the first 3 months, five appointments in the first 6 months or six appointments in the first 12 months. b Weight loss (5%) is the amount shown to prevent 58% of new diabetes (Knowler et al, 2002; Tuomilehto et al, 2001) . approach can be effective. The uptake of the programme into primary care has been well received, with three-quarters of practices continuing to recruit patients despite no additional funding being provided for practice implementation. Over a third of all patients followed up achieved a clinically meaningful weight loss of 5% or more at 12 months. While practices self-selecting in the Counterweight Programme may have a particular interest in obesity, none of these practices had ongoing weight management programmes prior to agreeing to participate in this research. These practices are broadly representative and include large practices, single-handed GP practices, rural and urban, and practices from high and low deprivation areas.
The positive outcomes of the Counterweight model contrast with other weight management interventions in primary care. The interventions that failed to improve patient weight loss outcomes primarily focused on limited clinician upskilling and did not use other strategies to empower clinicians to change clinical practice or empower patients (Cadman & Findlay, 1998; Moore et al, 2003a, b; Wollard et al, 2003) . Our findings are in agreement with other studies that have shown a patient empowerment model to be effective in improving patient outcomes. Anderson et al (1995) and Pibernik-Okanovic et al (2004) demonstrated that empowerment-based education programmes can improve metabolic control and quality of life for patients with diabetes.
Around one in five practices withdrew from the programme citing reasons such as lack of resources and time, and changes in clinical staff. It is important to note that practices were asked to incorporate the programme into routine clinical care without additional funding and this may have been a significant barrier. At present, obesity is not a priority in the UK GP contract and PCN time is not funded for weight management. A qualitative study is currently underway, which will provide important insight into factors influencing practice uptake, programme implementation and sustainability. These findings will be important for the wider implementation of the Counterweight model into primary care in the future.
Practices were successful in implementing a structured approach to care, with over 90% of patients receiving one of the core lifestyle interventions of individual or group therapy, with individual intervention being more popular. This may reflect a lack of appropriate facilities, logistical problems in running groups in practices or a lack of confidence in facilitating group programmes. Groups run outside of the practice in a community setting where a number of practices could refer may be an alternative to providing patient support structures.
A small proportion of patients had progressed on to second-line interventions during the 12-month period. There is a lack of certainty as to whether patients were routinely reviewed at the quarterly intervals defined in the pathway and offered second-line interventions if required. Access to dietetic and psychology services, and secondary clinics may have also have been a limiting factor. The use of pharmacotherapy was influenced by local formulary protocols and GP preferences. Further quantitative and qualitative analysis will be performed to explore this further and will be reported in a final outcomes paper.
Just under half the patients attended the required number of appointments. Completers had a greater mean weight loss and were more likely to achieve a clinically significant weight loss of 5% or more compared to noncompleters. It has to be recognised that not all patients are appropriate for intensive management and more rigorous patient screening may improve patient selection. A qualitative study will also explore patients' experience of the programme, which will provide important insight into the relative effectiveness of various patient empowerment strategies.
Three-quarters of patients recruited had at least one obesity-related comorbidity at baseline. Comorbidity recording was based on coding within the primary care medical notes, rather than on baseline (screening) measures and thus may underestimate the number of patients with obesityrelated disease. Given that around one-quarter of patients enlisted were morbidly obese, with a high prevalence of obesity-related disease, it seems that the Counterweight model is mainly being used to manage diseases, which have developed secondary to obesity. This is consistent with other findings that have shown primary care clinicians target patients with existing disease for obesity management (Stafford et al, 2000; Bramlage et al, 2004; Simkin-Silverman et al, 2005) .
There is good evidence that moderate weight loss of 3 or 4 kg (5%) can significantly reduce the risk of developing type II diabetes (Tuomilehto et al, 2001; Knowler et al, 2002) . Obesity management is also central to the prevention of CHD and cancer, the two main causes of death in the UK (Calle et al, 2003) . Further research is required to examine relative cost-effectiveness of intervention at different BMI levels. It may be more cost effective for primary care to intervene at lower levels of BMI for primary prevention with a higher chance of success rather than targeting patients with existing disease. A health economic analysis within the Counterweight Programme is underway.
Conclusion
The Counterweight Programme provides a promising model to improve the management of obesity in primary care. Preliminary results show a comprehensive approach to engaging clinicians to change clinical practice and to empower patients to change lifestyle is effective. It is envisaged that final programme outcomes will be disseminated in 2006 and will include changes in secondary end points such as blood pressure, lipids and diabetes control. Results of the Counterweight qualitative study and health economics will be important in determining the potential for widespread dissemination and use of this model in the primary care setting.
